MS vs STRO
Morgan Stanley (MS) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
MS does not have a complete income-statement cache yet.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
MS currently screens at market cap $344.27B and trailing P/E 19.8. STRO currently screens at market cap $470.8M.
Not investment advice. Open the MS and STRO stock pages for the full models.
Not investment advice.